Omeros Corporation (OMER) Social Stream

Featured Post From StockTwits About OMER

$OMER https://ir.travere.com/news-releases/news-release-details/travere-therapeutics-announces-positive-topline-interim-results
Travere IgA-N interim data out. At a glance… it looks pretty good and it’s orally administered. Meanwhile Greg said he “aims” to have ARTEMIS data out end of next year…. Looks like we won’t see the data next year…

“After 36 weeks of treatment, patients receiving sparsentan achieved a mean reduction in proteinuria from baseline of 49.8 percent, compared to a mean reduction in proteinuria from baseline of 15.1 percent for irbesartan-treated patients (p<0.0001).”